A citation-based method for searching scientific literature

Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander, Lyle W Ostrow, David Schoenfeld, Eric A Macklin, Daniel A Norris, Georgios Manousakis, Matthew Crisp, Richard Smith, C Frank Bennett, Kathie M Bishop, Merit E Cudkowicz. Lancet Neurol 2013
Times Cited: 385



Kevin D Foust, Desirée L Salazar, Shibi Likhite, Laura Ferraiuolo, Dara Ditsworth, Hristelina Ilieva, Kathrin Meyer, Leah Schmelzer, Lyndsey Braun, Don W Cleveland, Brian K Kaspar. Mol Ther 2013
Times Cited: 124




List of shared articles



Times cited


Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy.
Marisa Cappella, Pierre-François Pradat, Giorgia Querin, Maria Grazia Biferi. J Neuromuscul Dis 2021
4

Gene-based therapies for neurodegenerative diseases.
Jichao Sun, Subhojit Roy. Nat Neurosci 2021
8

Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis.
Maria Elena Cicardi, Lara Marrone, Mimoun Azzouz, Davide Trotti. EMBO J 2021
3

Gene therapy for ALS: A review.
Defne A Amado, Beverly L Davidson. Mol Ther 2021
4

Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.
Gayathri R Ediriweera, Liyu Chen, Justin J Yerbury, Kristofer J Thurecht, Kara L Vine. Mol Pharm 2021
1

Treatment of a Mouse Model of ALS by In Vivo Base Editing.
Colin K W Lim, Michael Gapinske, Alexandra K Brooks, Wendy S Woods, Jackson E Powell, M Alejandra Zeballos C, Jackson Winter, Pablo Perez-Pinera, Thomas Gaj. Mol Ther 2020
47


Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
Elena Abati, Nereo Bresolin, Giacomo Comi, Stefania Corti. Expert Opin Ther Targets 2020
9

Studying ALS: Current Approaches, Effect on Potential Treatment Strategy.
E I Ustyantseva, S P Medvedev, S M Zakian. Adv Exp Med Biol 2020
2

Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis.
G Y Wang, S L Rayner, R Chung, B Y Shi, X J Liang. Mater Today Bio 2020
6



Single chain variable fragment antibodies directed against SOD1 ameliorate disease in mutant SOD1 transgenic mice.
Ghanashyam D Ghadge, Brian K Kay, Claire Drigotas, Raymond P Roos. Neurobiol Dis 2019
9

RNA Dysregulation in Amyotrophic Lateral Sclerosis.
Zoe Butti, Shunmoogum A Patten. Front Genet 2019
55